Conventional and complementary therapies: A tale of two research standards?

Journal of Clinical Oncology

Volumn 28, Issue 12, 2010, Pages 1979-1981

  Levine, Mark N ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; VENLAFAXINE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CYCLOHEXANOL DERIVATIVE; DEOXYCYTIDINE; DRUG DERIVATIVE; PEPTIDE HYDROLASE;

ACUPUNCTURE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; DECISION MAKING; DRUG EFFICACY; EDITORIAL; ENZYME THERAPY; FOLLOW UP; HOT FLUSH; LIVER METASTASIS; OUTCOME ASSESSMENT; PANCREAS CANCER; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; ALTERNATIVE MEDICINE; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIET THERAPY; EVIDENCE BASED MEDICINE; HUMAN; MORTALITY; NEOPLASM; NOTE; RISK ASSESSMENT; STANDARD; TIME; TREATMENT OUTCOME;

ACUPUNCTURE THERAPY; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS AS TOPIC; COMPLEMENTARY THERAPIES; CYCLOHEXANOLS; DEOXYCYTIDINE; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; HOT FLASHES; HUMANS; NEOPLASMS; PEPTIDE HYDROLASES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 77951631053     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.28.5320     Document Type: Editorial

References (15)

1. Ernst E, Resch KL, Mills S, et al: Complementary medicine: A definition. Br J Gen Pract 45:506, 1995
2. Sagar SM: Alternative therapies as primary treatment for cancer, in Abrams DI, Well AT (eds): Integrative Oncology. New York, NY, Oxford University Press, 2009, pp 502-527
3. National Institute of Complementary Medicine: Understanding complementary medicine. http://nicm.edu.au/content/view/31/35/
4. Walker EM, Rodriguez AI, Kohn B, et al: Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: A randomized controlled trial. J Clin Oncol 28:634-640, 2010
5. Chabot JA, Tsai W-Y, Fine RL, et al: Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer. J Clin Oncol 28:2058-2063, 2010
6. Evidence-Based Medicine Working Group: Evidence-based medicine: A new approach to teaching the practice of medicine. JAMA 268:2420-2425, 1992
7. Sackett DL, Rosenberg WM, Gray JA, et al: Evidence based medicine: What is it and what it isn't. BMJ 312:71-72, 1996
8. Sackett DL, Richardson WS, Rosenberg W, et al: Evidence-Based Medicine: How to Practice and Teach EBM. London, United Kingdom, Churchill Livingstone, 1997
9. Kaul S, Diamond GA: Good enough: A primer on the analysis and interpretation of noninferiority trials. Ann Intern Med 145:62-69, 2006 (Pubitemid 46780603)
10. White AR: Acupuncture research methodology, in Lewith G, Jonas WB, Walach H (eds): Clinical Research in Complementary Therapies: Principles, Problems and Solutions. Edinburgh, United Kingdom, Churchill Livingstone 2002, pp 307-323
11. Sagar SM: Acupuncture as an evidence-based option for symptom control in cancer patients. Curr Treat Options Oncol 9:117-126, 2008
12. Vickers AJ: Placebo controls in randomized trials of acupuncture. Eval Health Prof 25:421-435, 2002
13. Loprinzi CL, Kugler JW, Sloan JA, et al: Venlafaxine in management of hot flashes in survivors of breast cancer: Results of a randomized trial. Lancet 356:2059-2063, 2000 (Pubitemid 32009821)
14. Ernst E: What's the point of rigorous research on complementary/ alternative medicine? J R Soc Med 95:211-213, 2002
15. Deng GE, Frenkel M, Cohen L, et al: Evidence-based clinical practice guidelines for integrative oncology: Complementary therapies and botanicals. J Soc Integr Oncol 7:85-120, 2009